Home › Funds › Mediolanum International Funds Ltd › GILD

Mediolanum International Funds Ltd position in GILD

GILEAD SCIENCES INC · Health Care

Mediolanum International Funds Ltd reported holding 342,560 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$51.8M, representing 0.44% of its reported portfolio and ranking #41 among its reported holdings. Mediolanum International Funds Ltd has disclosed GILD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)342.56K sh
Reported value held$51.82M
Portfolio Weight0.44%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Mediolanum International Funds Ltd's GILD position evolved

Mediolanum International Funds Ltd first disclosed a stake in GILD in Q1 2024 at 62,892 shares (US$4.6M). The position peaked in Q3 2026 at 342,560 shares, worth US$51.8M. Across 11 filings, Mediolanum International Funds Ltd increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 342,560 shares valued at US$51.8M — an increase of 292,533 shares quarter over quarter.. Notable position changes include a 141% increase in Q2 2024 (shares rose 22% over the following quarter), a 85% increase in Q2 2025 (shares were roughly flat over the following quarter), a 585% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 62.89K $4.59M New
Q2 2024 151.28K $9.72M Add
Q3 2024 61.66K $5.15M Reduce
Q4 2024 57.91K $5.32M Reduce
Q1 2025 97.43K $10.89M Add
Q2 2025 179.83K $19.90M Add
Q3 2025 189.80K $21.38M Add
Q4 2025 161.75K $19.92M Reduce
Q1 2026 159.55K $21.75M Reduce
Q2 2026 50.03K $6.32M Reduce
Q3 2026 342.56K $51.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Mediolanum International Funds Ltd held GILD?

Mediolanum International Funds Ltd has disclosed GILD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Mediolanum International Funds Ltd's current position in GILD?

As of Q3 2026, Mediolanum International Funds Ltd holds 342.56K shares of GILD (GILEAD SCIENCES INC), valued at $51.82M, representing 0.44% of its reported portfolio and ranking #41.

Has Mediolanum International Funds Ltd been buying or selling GILD?

In the latest 13F filing (Q3 2026), Mediolanum International Funds Ltd increased its position in GILD. The position peaked in Q3 2026 at 342.56K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.